Neusoft Medical designs and manufactures medical imaging systems and provides related services. The company offers a range of products including CT, MRI, X-Ray, and ultrasound machines, along with advanced medical technology training and support.

Neusoft Medical

Neusoft Medical | 27,250 followers on LinkedIn. Innovating for you | Neusoft Medical Systems Co., Ltd. (Neusoft Medical) is a leading global clinical diagnosis and treatment solution provider. 
Headquartered in China, with subsidiaries in the United States, Dubai, Peru, Brazil, Kenya, Germany, Korea, Thailand and a representative office in Vietnam.

Business Unit Manager I Business Development I Sales I Commercial Strategy & Tendering Expert I Medical Devices Industry

Antonio Fernandes Teixeira

Mercedes Ho

Physicist, Medical Imaging Research

Lucretiu Popescu

SENIOR STRATEGIC ALLIANCE AND INVESTMENT（M&A） MANAGER

HongBo (Aaron) Zhao

Intelligence is Everywhere. We believe in a future where AI is accessible to everyone, seamlessly integrated into every aspect of medical imaging. From enhancing diagnostic accuracy to streamlining workflows, AI-powered solutions are reshaping healthcare and elevating patient outcomes. Join us at the booth 4340 in the South Hall at the Radiological Society of North America (RSNA) 2024 as we showcase how AI is transforming diagnostics and ensuring quality care reaches every patient, everywhere. #NeusoftMedical #Innovatingforyou #RSNA24 #AI

Case of Fracture, Pneumothorax Patient Information: Male , 41 years old Presentation： Chest pain, breathing difficulties Rib fracture, scapula fracture, pneumothorax, subcutaneous air accumulation #NeusoftMedical #InnovatingforYou #CT #Clinicalcase

Intelligent is Everywhere. Join us at Radiological Society of North America (RSNA) 2024 to see how Neusoft Medical Systems is transforming healthcare by embedding AI across diagnostics to ensure quality care reaches every patient. Connect with our experts and experience how we're making intelligent healthcare accessible to all. #NeusoftMedical #InnovatingforYou #RSNA24 #AI #artificialintelligence

Case of Lung tumor, Pericardial effusion Patient Information: Male, 40 years old Presentation: Diagnosed with lung cancer 4 months ago, Post radiotherapy. Chest tightness and shortness of breath appeared half a month ago, which worsened after activities. Imaging Findings： •Pericardial effusion •Multiple enlarged lymph nodes in the mediastinum and bilateral hilar pulmonary areas •Partial Bone density abnormalities seen in the spines, bone metastases is considered #NeusoftMedical #InnovatingforYou #ClinicalCase #CT

Case of Pneumothorax, Pulmonary artery compression Patient Information: Female, 77 years Presentation： Acute chest pain, breathing difficulties Imaging Findings： • Pneumothorax, right lung parenchyma compression and atrophy • Poor CM filling of the right pulmonary artery #NeusoftMedical #InnovatingforYou

NeuAngio-CT providing One-stop Multimodality Interventional Diagnosis and Treatment Solution NeuAngio-CT can provide high-end wide-coverage Angio-CT one-stop #multimodality comprehensive #interventional diagnosis and treatment solution which improve the efficiency of surgical operations with preoperative planning, intraoperative guidance, and postoperative evaluation of interventional surgeries all completed in just one stop. At the same time, medical risks experienced by patients during transportation such as infections and unstable vital signs are effectively eliminated. An integrated diagnosis and treatment model supported by the one-stop #TRO solution and one-stop #stroke solution, the product offers great advantages in the construction of emergency facilities such as chest pain centers, stroke centers, and trauma centers. #NeusoftMedical #InnovatingforYou

CTA/CTV BoneSupression Case Study The implementation of a deep learning-based skull suppression technique for CTA/CTV images effectively addresses the issue of mismatch between NCCT and CTA sequences observed in patients with incorporated conditions A 49-year-old female with a four-day history of headache and vomiting, grade 3 hypertension, underwent cranial CTA/CTV angiography. The patient was restless and changed positions (as shown in Image 1). The NCCT and CTA sequences were not aligned, preventing the performance of routine vascular subtraction imaging. A single CTA/CTV image sequence is used to simultaneously segment skull identification and reconstruct skull suppression image sequences, and artificial intelligence recognition is applied to three-dimensional spatial pixel values, forming CTA and CTV images (Image 2). The intraoperative DSA is compared with the effect of deep learning CTA (Image 3) #NeusoftMedical #InnovatingforYou #CT #clinical #CTA

The application of new molecular probes in clinical practice not only improves the accuracy, sensitivity and specificity of tumor diagnosis, but also provides new means for early diagnosis of diseases and evaluation of treatment effects, which is of great significance for improving patient survival rate and quality of life. For example, new molecular probes such as FAPI (Fibroblast Activating Protein Inhibitor) and PSMA (Prostate Specific Membrane Antigen) target tumor-related cells, judge the nature of lesions from the perspective of tumor generation mechanism, and provide new technologies for the diagnosis of tumor diseases, filling gaps in certain fields. In addition, the use of new molecular probes also shows the characteristics of high sensitivity and strong specificity, showing great clinical application value in the diagnosis and treatment of various malignant tumors such as neuroendocrine tumors, prostate cancer, esophageal cancer, and gastric cancer, providing patients with more treatment options and better treatment effects. #NeusoftMedical #InnovatingforYou #PETCT

Bonjour! This year at JFR2024, we are excited to share and present our latest AI-powered diagnostic imaging system and healthcare solutions. AI patient experience is the key to creating impact in healthcare; this is what Neusoft Medical is committed to supporting healthcare providers in meeting the evolving needs. At the booth, we showcased our fabulous NeuViz Epoch CT with a rotation speed of 0.2s, freezing fast-moving structures in scans. Today, an increasing number of patients with different clinical conditions require high-quality CT imaging – ranging from patients with a high or irregular heart rate to those with limited breath-hold capabilities or even pediatric patients. Now, we're making our system available to a wider range of clinical institutions. We are committed to continuously offering more ways. #NeusoftMedical #InnovatingforYou #JFR2024

Come and discuss with us how we can together advance the mult-disciplinary imaging sector, and improve services and care at each stage of the patient’s care journey at JFR 2024. #NeusoftMedical #InnovatingforYou #JFR2024

Metric
Company Name	Neusoft Medical
Symbol
MSH ID	COM:NEUSOFTMEDICAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Equipment & Supplies
Country	CN
Stage
Employee Count
Website	neusoftmedical.com
LinkedIn	neusoft-medical-systems-co-ltd-
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NEUS

COM:NEUSOFTMEDICAL

Neusoft Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue